O slideshow foi denunciado.
Seu SlideShare está sendo baixado. ×

Presentation (12).pptx

Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Próximos SlideShares
Drug degradation
Drug degradation
Carregando em…3
×

Confira estes a seguir

1 de 7 Anúncio

Mais Conteúdo rRelacionado

Semelhante a Presentation (12).pptx (20)

Mais recentes (20)

Anúncio

Presentation (12).pptx

  1. 1. Physical Degradation : • Definition : • It is the degradation which results into the change of physical nature of drug. The formulation is totally changed by way of appearance, organoleptic properties, hardness, brittleness, particle size. • Physical degradation includes: • Loss of volatile components • Loss of water • Absorption of water
  2. 2. • Crystal growth • Polymorphic changes • Colour changes • 1. LOSS OF VOLATILE COMPONENTS: • Volatile components such as alcohol, ether, camphor, iodine, volatile oil etc. escape from the formulation e.g. Nitroglycerine from drugs evaporates.
  3. 3. Measures to Prevent Loss of Volatile Components: • Such products should be placed in well closed container. • To decrease temperature as increase in temperature will increase volatility, product should be placed in a cool place. • 2. LOSS OF WATER: • Loss of water from o/w emulsions thus the stability changes. • Water evaporates from efflorescent salts such as Borax and sodium bisulphate etc. • Water evaporates causing crystal growth.
  4. 4. Measures to Prevent Loss of Water: • Water loss may be prevented by storing the product in well closed container. • 3. CRYSTAL GROWTH: • In solutions after super saturation of solvent crystal growth occurs e.g. injection of calcium gluconate • In suspension crystals settle down and caking occurs and suspension becomes unstable e.g. ophthalmic preparations.
  5. 5. Prevention of Crystal Growth: • In case of solutions stabilizers are employed. • In case of suspension minimum temperature flocculation should be managed. • Incorporation of surface active agents. • By increasing viscosity of suspending medium. • 4. ABSORPTION OF WATER: • Hygroscopic drugs such as glycerin suppositories absorb • Water from atmosphere causing physical degradation.
  6. 6. Preventive measure for absorption of water: • Product should be placed in well closed container. • 5. POLYMORPHIC CHANGES: • In polymorphic changes crystals form change. A stable crystal form is lost. • Measures to prevent polymorphic changes: • Formulated product should contain a stable crystalline form of the drug.
  7. 7. 6. COLOUR CHANGES: • Colour changes are of two types: • Loss of color • Development of color • Loss of color is due to pH changes. • Development of color is due to reducing agents, water and U.V rays. • Prevention of Colour Changes: • PH should not be changed. • Exposure to light should be avoided.

×